Liat Shargian

Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study

Moshe Yeshurun, Ofer Shpilberg, Corina Herscovici et al. · Biology of Blood and Marrow Transplantation · 2015 · 79 citations · Full text

Transplant Rejection, Cell Therapy, Transplantation +15

Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients – a matched control multicenter cohort study

Ron Ram, Sigal Grisariu, Liat Shargian et al. · Haematologica · 2021 · 62 citations · Full text

Clinical Immunology, Elderly Patients, Immunodeficiencies +21

The unique presentation of SARS-CoV-2 Infection in patients with B-cell depletion: definition of ‘persistent inflammatory sero-negative COVID’

Ana Belkin, Avshalom Leibowitz, Liat Shargian et al. · Clinical Microbiology and Infection · 2022 · 36 citations · Full text

Viral Persistence, Sars-cov-2 Infection, Medicine +10

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study

Oren Pasvolsky, Shai Shimony, Ron Ram et al. · Annals of Hematology · 2021 · 28 citations

Hematological Malignancy, Transplantation, Mixed-phenotype Acute Leukemia +9

Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational Study

Adi Shacham‐Abulafia, Pia Raanani, David Lavie et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 27 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Oncology +7